Takashi Muramatsu

Preprocedural physiological assessment of coronary disease patterns to predict haemodynamic outcomes post-PCI

Kotoku N, Ninomiya K, Masuda S, O’Leary N, Garg S, Naito M, Miyashita K, Tobe A, Kageyama S, Tsai TY, Revaiah PC, Tu S, Kozuma K, Kawashima H, Ishibashi Y, Nakazawa G, Takahashi K, Okamura T, Miyazaki Y, Tateishi H, Nakamura M, Kogame N, Asano T, Nakatani S, Morino Y, Ishida M, Katagiri Y, Ono M, Hara H, Sotomi Y, Tanabe K, Ozaki Y, Muramatsu T, Dijkstra J, Onuma Y, Serruys P

November 14, 2023 | 10.4244/EIJ-D-23-00516

Online three-dimensional OFDI-guided versus angiography-guided PCI in bifurcation lesions: design and rationale of the randomised OPTIMUM trial

Miyazaki Y, Muramatsu T, Asano T, Katagiri Y, Sotomi Y, Nakatani S, Takahashi K, Kogame N, Higuchi Y, Ishikawa M, Kyono H, Yano M, Ozaki Y, Serruys P, Okamura T, Onuma Y

March 19, 2021 | 10.4244/EIJ-D-18-00902

A novel four-dimensional angiographic approach to assess dynamic superficial wall stress of coronary arteries in vivo: initial experience in evaluating vessel sites with subsequent plaque rupture

Wu X, von Birgelen C, Muramatsu T, Li Y, Holm N, Reiber J, Tu S

October 11, 2017 | 10.4244/EIJ-D-16-01020

Clinical outcomes of “complete, partially complete, and incomplete” revascularisation at five-year follow-up after percutaneous intervention of unprotected left main coronary artery disease with drug-eluting stents

Zhang Y-J, Iqbal J, Ye F, Zhang J, Bourantas C, Pan D-R, Tian N, Kan J, Qian X-S, Ding S, Li F, Zhang A, Liu Y, Muramatsu T, Onuma Y, Garcia-Garcia H, Serruys P, Chen S

October 10, 2016 | 10.4244/EIJY15M12_06

New implication of three-dimensional optical coherence tomography in optimising bifurcation PCI

Onuma Y, Okamura T, Muramatsu T, Uemura S, Serruys P

May 19, 2015 | 10.4244/EIJV11SVA15

Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial

Nakatani S, Onuma Y, Ishibashi Y, Muramatsu T, Iqbal J, Zhang Y-J, van Geuns R, Ormiston J, Serruys P

March 20, 2015 | 10.4244/EIJV10I11A218

Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial

Bourantas C, Farooq V, Zhang Y-J, Muramatsu T, Gogas B, Thuesen L, McClean D, Chevalier B, Windecker S, Koolen J, Ormiston J, Whitbourn R, Dorange C, Rapoza R, Onuma Y, Garcia-Garcia H, Serruys P

March 20, 2015 | 10.4244/EIJY14M04_11

Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial

Zhang Y-J, Bourantas C, Muramatsu T, Iqbal J, Farooq V, Diletti R, Campos C, Onuma Y, Garcia-Garcia H, Serruys P

October 20, 2014 | 10.4244/EIJV10I6A118

Fast virtual functional assessment of intermediate coronary lesions using routine angiographic data and blood flow simulation in humans: comparison with pressure wire – fractional flow reserve

Papafaklis M, Muramatsu T, Ishibashi Y, Lakkas L, Nakatani S, Bourantas C, Ligthart J, Onuma Y, Echavarria-Pinto M, Tsirka G, Kotsia A, Nikas D, Mogabgab O, van Geuns R, Naka K, Fotiadis D, Brilakis E, Garcia-Garcia H, Escaned J, Zijlstra F, Michalis L, Serruys P

September 28, 2014 | 10.4244/EIJY14M07_01

Lessons learned from acute and late scaffold failures in the ABSORB EXTEND trial

Ishibashi Y, Onuma Y, Muramatsu T, Nakatani S, Iqbal J, Garcia-Garcia H, Bartorelli AL, Whitbourn R, Abizaid A, Serruys P

August 19, 2014 | 10.4244/EIJV10I4A78

Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months

Serruys P, Onuma Y, Garcia-Garcia H, Muramatsu T, van Geuns R, De Bruyne B, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert K, Rapoza R, Ormiston J

March 20, 2014 | 10.4244/EIJV9I11A217

Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation

Radu M, Räber L, Heo J, Gogas B, Jørgensen E, Kelbæk H, Muramatsu T, Farooq V, Helqvist S, Garcia-Garcia H, Windecker S, Saunamäki K, Serruys P

January 20, 2014 | 10.4244/EIJV9I9A183

Single-vessel or multivessel PCI in patients with multivessel disease presenting with non-ST-elevation acute coronary syndromes

Onuma Y, Muramatsu T, Girasis C, Kukreja N, Garcia-Garcia H, Daemen J, Gonzalo N, Piazza N, Eindhoven J, van Domburg R, Serruys P

December 27, 2013 | 10.4244/EIJV9I8A154

Complex bifurcation percutaneous coronary intervention with the Absorb bioresorbable vascular scaffold

Dzavik V, Muramatsu T, Crooks N, Nakatani S, Onuma Y

November 29, 2013 | 10.4244/EIJV9I7A145

In vivo assessment of the three-dimensional haemodynamic micro-environment following drug-eluting bioresorbable vascular scaffold implantation in a human coronary artery: fusion of frequency domain optical coherence tomography and angiography

Papafaklis M, Bourantas C, Farooq V, Diletti R, Muramatsu T, Zhang Y-J, Fotiadis D, Onuma Y, Garcia-Garcia H, Michalis L, Serruys P

November 29, 2013 | 10.4244/EIJV9I7A147

The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials

Gogas B, Bourantas C, Garcia-Garcia H, Onuma Y, Muramatsu T, Farooq V, Diletti R, van Geuns R, De Bruyne B, Chevalier B, Thuesen L, Smits PC, Dudek D, Koolen J, Windecker S, Whitbourn R, McClean D, Dorange C, Miquel-Hebert K, Veldhof S, Rapoza R, Ormiston J, Serruys P

October 25, 2013 | 10.4244/EIJV9I6A115

Clinical and angiographic outcomes following first-in-man implantation of a novel thin-strut low-profile fixed-wire stent: the Svelte Coronary Stent Integrated Delivery System first-in-man trial

Diletti R, Garcia-Garcia H, Bourantas C, van Geuns R, Van Mieghem NM, Agostoni P, Muramatsu T, Farooq V, Spencer R, de Schepper J, Pomeranz M, Stella P, Serruys P

May 21, 2013 | 10.4244/EIJV9I1A18

Takashi Muramatsu

Latest news